Article Information
History
- October 3, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Qiongxin Wang, PhD1,2,3,
- Mohamed Ameen Ismahil, PhD1,3,
- Yujie Zhu, MD, PhD1,3,
- Gregg Rokosh, PhD1,3,
- Tariq Hamid, PhD1,3,
- Guihua Zhou, MD, PhD1,
- Steven M. Pogwizd, MD1 and
- Sumanth D. Prabhu, MD1,3,*
- 1Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL
- 2Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China,
- 3Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
- ↵*Corresponding Author: Sumanth D. Prabhu, MD, Lewin Distinguished Professor and Chief Division of Cardiologym, Washington University School of Medicine 660 S. Euclid Ave, CB 8086, St. Louis, MO 63110 Tel: 314-362-8908, Fax: 314-454-5550, Email: prabhu{at}wustl.edu
Posted October 03, 2024.
CD206+IL-4Rα+ MACROPHAGES ARE DRIVERS OF ADVERSE CARDIAC REMODELING IN ISCHEMIC CARDIOMYOPATHY
